Tardive dyskinesia

"I believe more than 1 million Americans suffer from TD. It seems conservative to say that in 1991, tens of millions of TD victims are alive around the world…..Psychiatry has unleashed an epidemic of neurological disease on the world. Even if TD were the only permanent disability produced by these drugs, by itself, this would be among the worst medically-induced disasters in history."—Peter Breggin, M.D.

Tardive Dyskinesia "resulted in painful, disfiguring twitches and spasms. Afflicted individuals were unable to work and carry on a normal family and social life. Often depressed and humiliated by their physical appearance, they withdrew from loved ones."-- Dr. P. Breggin & D. Cohen, Ph.D, Your Drug May Be Your Problem. (Perseus Books, 1999. pp.76-82).

The standard neuroleptics like Thorazine and Haldol have had quite a litany of harm with the tardive dyskinesia and all. ....Let's talk about Zyprexa. It has a different profile. So it may not cause as much tardive dyskinesia. It may not cause as many Parkinsonian symptoms. But it causes a whole range of new symptoms. So, for example, it's more likely to cause diabetes. It's more likely to cause pancreatic disorders. It's more likely to cause obesity and appetite-disregulation disorders. ......In fact, researchers in Ireland reported in 2003 that since the introduction of the atypical antipsychotics, the death rate among people with schizophrenia has doubled. They have done death rates of people treated with standard neuroleptics and then they compare that with death rates of people treated with atypical antipsychotics, and it doubles. It doubles! It didn't reduce harm. In fact, in their seven-year study, 25 of the 72 patients died. [2005] Psychiatric Drugs: An Assault on the Human Condition Street ---Robert Whitaker

External links
TD Case Settled After Breggin Testimony

[1997] Jury Awards $1.3 million to Tardive Dyskinesia Victim--Appeals Judge Increases Award to $2 million citing Dr. Breggin's testimony

[2000] $6.7 million Awarded by Jury in Risperdal Tardive Dyskinesia Case

$1.6 Million Tardive Dyskinesia Verdict on October 14, 2005

Tardive Dyskinesia and Tardive Dementia caused by Neuroleptic Drugs

Landmark Victory in First Canadian Tardive Dyskinesia Trial